Research Division, Institute of Mental Health, Buangkok Green Medical Park, 10 Buangkok View, 539747, Singapore.
Research Division, Institute of Mental Health, Buangkok Green Medical Park, 10 Buangkok View, 539747, Singapore.
Psychiatry Res. 2019 Apr;274:400-408. doi: 10.1016/j.psychres.2019.02.077. Epub 2019 Mar 1.
There is limited evidence of a direct comparison of the psychometric performance of generic preference-based measures in patients with mental illness in an Asian patient population. The current study aimed to compare the test-retest reliability, convergent and known-group validity and magnitude of change in scores of the EuroQol Five-Dimension, Health Utility Index Mark 3 (HUI3) and Short-Form Six-Dimension (SF-6D) measures in patients with depression and patients with schizophrenia spectrum disorder. 500 patients were recruited from a tertiary psychiatric institution in Singapore. The Schizophrenia Quality of Life Scale (SQLS), 8-item Patient Health Questionnaire, Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q), and Positive and Negative Syndrome Scale were also included. In the schizophrenia sample, the SF-6D was found to have higher test-retest validity, convergent validity with SQLS domain scores, known-group validity and magnitude of change in scores over 6-month follow up than other measures. In the depression sample, the HUI3 was found to have higher test-retest reliability, convergent validity with Q-LES-Q, known group validity and magnitude of change in scores than other measures. Results suggest that the SF-6D and HUI3 to be more suitable as a utility measure for patients with schizophrenia and depression in an Asian patient population.
在亚洲患者人群中,针对精神疾病患者,很少有直接比较通用偏好量表心理测量性能的证据。本研究旨在比较在抑郁症患者和精神分裂症谱系障碍患者中,欧洲五维健康量表(EQ-5D)、健康效用指数标记 3 版(HUI3)和简短六维健康量表(SF-6D)测量的重测信度、聚合和已知组有效性以及评分变化幅度。从新加坡的一家三级精神病院招募了 500 名患者。还包括精神分裂症生活质量量表(SQLS)、8 项患者健康问卷、生活质量享受和满意度问卷(Q-LES-Q)以及阳性和阴性综合征量表。在精神分裂症样本中,SF-6D 具有更高的重测信度、与 SQLS 领域得分的聚合效度、已知组有效性以及在 6 个月随访期间的评分变化幅度,优于其他测量。在抑郁症样本中,HUI3 具有更高的重测信度、与 Q-LES-Q 的聚合效度、已知组有效性和评分变化幅度,优于其他测量。结果表明,SF-6D 和 HUI3 更适合作为亚洲患者人群中精神分裂症和抑郁症患者的效用测量工具。